Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Major facilitator superfamily domain-containing protein 9 (MFSD9) is a membrane protein encoded by the MFSD9 gene in humans, also designated SLC67A2 as its systematic solute carrier family name[3][4][5]. It is classified as a potential or "atypical" solute carrier (SLC), meaning it has sequence similarity and predicted function as a transporter but does not follow the standard SLC nomenclature[3][1]. MFSD9 is predicted to localize to cell membranes and is involved in the general function of transmembrane transport of small solutes, consistent with membership in the major facilitator superfamily (MFS) of transporters[4][3][1]. Its specific substrates, physiological roles, disease associations, and interaction with drugs or biomarker relevance have not yet been characterized in the literature or major biological databases. It is expressed in both central and peripheral organs in mammals[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major facilitator superfamily domain-containing protein 9 (MFSD9).